Mercator Medical S.A.
Mercator Medical S.A., together with its subsidiaries, manufactures and distributes disposable medical gloves, dressings, and non-woven fabric products in Poland, the Czech Republic, Ukraine, France, Hungary, Italy, Romania, Germany, rest of Europe, and Thailand. The company offers surgical and protective, sterile examination and protective, and household gloves; glove brackets; and household and… Read more
Mercator Medical S.A. (MRC) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.052x
Based on the latest financial reports, Mercator Medical S.A. (MRC) has a cash flow conversion efficiency ratio of 0.052x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł46.48 Million) by net assets (zł890.05 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Mercator Medical S.A. - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Mercator Medical S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Mercator Medical S.A. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Mercator Medical S.A. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Aileron Therapeutics Inc
NASDAQ:ALRN
|
-0.076x |
|
Kjell Group AB
ST:KJELL
|
0.245x |
|
AVE S.A.
AT:AVE
|
-1.291x |
|
OPAL Fuels Inc
NASDAQ:OPAL
|
0.038x |
|
Goodness Growth Holdings Inc
OTCQX:GDNSF
|
-0.028x |
|
Senstar Technologies Ltd
NASDAQ:SNT
|
0.009x |
|
Uniquest
KO:077500
|
-0.059x |
|
Wave Electronics Co. Ltd
KQ:095270
|
0.076x |
Annual Cash Flow Conversion Efficiency for Mercator Medical S.A. (2012–2024)
The table below shows the annual cash flow conversion efficiency of Mercator Medical S.A. from 2012 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | zł925.16 Million | zł-72.06 Million | -0.078x | -77758.80% |
| 2023-12-31 | zł859.71 Million | zł-86.00K | 0.000x | -100.25% |
| 2022-12-31 | zł1.01 Billion | zł40.79 Million | 0.040x | -90.80% |
| 2021-12-31 | zł1.15 Billion | zł503.00 Million | 0.439x | -35.69% |
| 2020-12-31 | zł1.04 Billion | zł712.47 Million | 0.683x | +138.32% |
| 2019-12-31 | zł134.46 Million | zł38.53 Million | 0.287x | +565.01% |
| 2018-12-31 | zł133.29 Million | zł-8.21 Million | -0.062x | -131.18% |
| 2017-12-31 | zł119.74 Million | zł23.67 Million | 0.198x | +46.90% |
| 2016-12-31 | zł123.46 Million | zł16.61 Million | 0.135x | +24.19% |
| 2015-12-31 | zł72.70 Million | zł7.88 Million | 0.108x | -42.04% |
| 2014-12-31 | zł67.21 Million | zł12.56 Million | 0.187x | +455.66% |
| 2013-12-31 | zł57.13 Million | zł1.92 Million | 0.034x | -89.02% |
| 2012-12-31 | zł24.69 Million | zł7.57 Million | 0.306x | -- |